Anke‐Peggy Holtorf

1.3k total citations
39 papers, 885 citations indexed

About

Anke‐Peggy Holtorf is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Anke‐Peggy Holtorf has authored 39 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Economics and Econometrics, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in General Health Professions. Recurrent topics in Anke‐Peggy Holtorf's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (15 papers) and Circadian rhythm and melatonin (5 papers). Anke‐Peggy Holtorf is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (15 papers) and Circadian rhythm and melatonin (5 papers). Anke‐Peggy Holtorf collaborates with scholars based in United States, United Kingdom and Switzerland. Anke‐Peggy Holtorf's co-authors include Rüssel J. Reiter, Thomas H. Champney, Craig A. McArdle, Richard W. Steger, Zoltán Kaló, Richard Ivell, Kenichi Furuya, Nigel S. Cook, E.C. Faulkner and John B. Watkins and has published in prestigious journals such as PLoS ONE, Endocrinology and Life Sciences.

In The Last Decade

Anke‐Peggy Holtorf

36 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anke‐Peggy Holtorf United States	16	283	242	115	111	90	39	885
David Rotter United States	16	32 0.1×	39 0.2×	51 0.4×	59 0.5×	6 0.1×	36	679
Andrea C. Wilson United States	14	52 0.2×	20 0.1×	37 0.3×	175 1.6×	8 0.1×	25	828
Jong‐Woo Kim South Korea	19	40 0.1×	46 0.2×	47 0.4×	60 0.5×	2 0.0×	67	924
Ching‐Feng Chiu Taiwan	19	40 0.1×	12 0.0×	37 0.3×	145 1.3×	13 0.1×	59	1.3k
Suzannah Bumpstead United Kingdom	8	98 0.3×	15 0.1×	41 0.4×	135 1.2×	14 0.2×	8	2.0k
Francisco Alba Spain	17	17 0.1×	40 0.2×	36 0.3×	93 0.8×	11 0.1×	85	825
Michael J. Wilkinson United States	18	83 0.3×	348 1.4×	138 1.2×	612 5.5×		56	1.6k
Christopher Kaiser United States	18	56 0.2×	17 0.1×	10 0.1×	100 0.9×	23 0.3×	35	856
Gary L. Gadbury United States	17	66 0.2×	16 0.1×	152 1.3×	178 1.6×	6 0.1×	43	1.2k
Moon H. Lee United States	14	18 0.1×	19 0.1×	28 0.2×	284 2.6×	22 0.2×	26	1.1k

Countries citing papers authored by Anke‐Peggy Holtorf

Since Specialization

Citations

This map shows the geographic impact of Anke‐Peggy Holtorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke‐Peggy Holtorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke‐Peggy Holtorf more than expected).

Fields of papers citing papers by Anke‐Peggy Holtorf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke‐Peggy Holtorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke‐Peggy Holtorf. The network helps show where Anke‐Peggy Holtorf may publish in the future.

Co-authorship network of co-authors of Anke‐Peggy Holtorf

This figure shows the co-authorship network connecting the top 25 collaborators of Anke‐Peggy Holtorf. A scholar is included among the top collaborators of Anke‐Peggy Holtorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke‐Peggy Holtorf. Anke‐Peggy Holtorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holtorf, Anke‐Peggy, et al.. (2025). Toward including environmental sustainability in Health Technology Assessment. International Journal of Technology Assessment in Health Care. 41(1). e70–e70.

Holtorf, Anke‐Peggy, et al.. (2024). Stakeholder perspectives on the current status and potential barriers of patient involvement in health technology assessment (HTA) across Europe. International Journal of Technology Assessment in Health Care. 40(1). e81–e81. 3 indexed citations

Zrubka, Zsombor, Annette Champion, Anke‐Peggy Holtorf, et al.. (2024). The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report. Value in Health. 27(4). 383–396. 10 indexed citations

Holtorf, Anke‐Peggy, et al.. (2024). The three-domain impact framework for characterizing impact of patient involvement in health technology assessment. International Journal of Technology Assessment in Health Care. 40(1). e52–e52. 3 indexed citations

Zrubka, Zsombor, Rossella Di Bidino, Anke‐Peggy Holtorf, et al.. (2023). OP59 Do Digital Health Terms Provide Sufficient Information To Allow For Health Technology Assessment?. International Journal of Technology Assessment in Health Care. 39(S1). S16–S16.

Holtorf, Anke‐Peggy, et al.. (2023). Ethical and legal considerations in social media research for health technology assessment: conclusions from a scoping review. International Journal of Technology Assessment in Health Care. 39(1). e62–e62. 3 indexed citations

Holtorf, Anke‐Peggy, et al.. (2023). Using social media research in health technology assessment: stakeholder perspectives and scoping review. International Journal of Technology Assessment in Health Care. 39(1). e63–e63. 2 indexed citations

Holtorf, Anke‐Peggy, et al.. (2021). Pilot approach to analyzing patient and citizen involvement in health technology assessment in four diverse low- and middle-income countries. International Journal of Technology Assessment in Health Care. 37(1). e1–e1. 3 indexed citations

Faulkner, E.C., Anke‐Peggy Holtorf, Surrey M. Walton, et al.. (2020). Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group. Value in Health. 23(5). 529–539. 75 indexed citations

10.

Cook, Nigel S., et al.. (2019). Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs. Frontiers in Medicine. 6. 82–82. 36 indexed citations

11.

Holtorf, Anke‐Peggy, et al.. (2019). External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage. Value in Health Regional Issues. 19. 122–131. 27 indexed citations

12.

Maniadakis, N, et al.. (2018). Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage. Applied Health Economics and Health Policy. 16(5). 591–607. 29 indexed citations

13.

He, Xiaoning, Jing Wu, Anke‐Peggy Holtorf, et al.. (2018). Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China. PLoS ONE. 13(1). e0191095–e0191095. 11 indexed citations

14.

Maniadakis, Nikos, Georgia Kourlaba, Jie Shen, & Anke‐Peggy Holtorf. (2017). Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status. BMC Health Services Research. 17(1). 371–371. 17 indexed citations

15.

Kaló, Zoltán, Anke‐Peggy Holtorf, Rafael Alfonso‐Cristancho, et al.. (2015). Need for Multicriteria Evaluation of Generic Drug Policies. Value in Health. 18(2). 346–351. 34 indexed citations

16.

Maniadakis, N, et al.. (2013). Systematic Review on the Impacts of Strict Pharmaceutical Price Controls. Value in Health. 16(7). A486–A486. 1 indexed citations

17.

Biskupiak, Joseph, Dori B. Reissman, & Anke‐Peggy Holtorf. (2012). Implementing CER: What Will It Take?. Journal of Managed Care Pharmacy. 18(5 Supp A). S19–S29. 6 indexed citations

18.

Holtorf, Anke‐Peggy, et al.. (2009). Systematic review on quality control for drug management programs: Is quality reported in the literature?. BMC Health Services Research. 9(1). 38–38. 3 indexed citations

19.

Holtorf, Anke‐Peggy, et al.. (1995). Development of optimized transfectoma cell lines for production of chimeric antibodies in hollow fiber cell culture systems. Biotechnology and Bioengineering. 45(4). 310–319. 11 indexed citations

20.

Holtorf, Anke‐Peggy, Kenichi Furuya, Richard Ivell, & Craig A. McArdle. (1989). Oxytocin Production and Oxytocin Messenger Ribonucleic Acid Levels in Bovine Granulosa Cells are Regulated by Insulin and Insulin-Like Growth Factor-I: Dependence on Developmental Status of the Ovarian Follicle*. Endocrinology. 125(5). 2612–2620. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact